Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence.

  title={Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence.},
  author={M. Sexton},
  journal={Journal of alternative and complementary medicine},
  • M. Sexton
  • Published 2020
  • Medicine
  • Journal of alternative and complementary medicine
Editor's Note: For those whose response to COVID-19 includes exploring beyond vaccines, conventional pharmaceuticals, and the watchful or healthy waiting until such tools might arrive, interest in cannabinoids has been high - and controversial. It has already stimulated one journal, the Liebert Cannabis and Cannabinoid Research, to issue a call for papers on COVID-19. The unique place of cannabis in the culture seems to always mark the herb with an exponential asterisk whenever basketed with… Expand
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
Advantages and disadvantages of cannabidiol (CBD), a non-intoxicating phytocannabinoid from the cannabis plant, as a potential agent for the treatment of COVID-19 are presented. Expand
The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
The mechanism underlying the hypotensive properties of cannabinoids should be urgently studied to understand if they can also lead to ACE-2 overexpression as other antihypertensive drugs do. Expand
The Immunopathology of COVID-19 and the Cannabis Paradigm
The anti-inflammatory function of cannabinoids in relation to inflammatory events that happen during severe COVID-19 disease, and how cannabinoids might help to prevent the progression from mild to severe disease is explored. Expand
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
It is speculated that beta-caryophyllene (BCP) could be a promising therapeutic and/or preventive candidate to target the triad of infection, immunity, and inflammation in COVID-19. Expand
Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
An overview of phytochemistry and pharmacology of compounds present in Cannabis extracts in the context of the current knowledge about their synergistic actions and the implications of clinical use in the treatment of selected diseases is provided. Expand
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review
Abstract Background In the context of the COVID-19 worldwide pandemic, an up-to-date review of current challenges in addictions isExpand
Objective. Inquire about the emerging scientific literature at the international level about the repercussion of the COVID-19 pandemic on addictions. Methodology. The Web of Science database was usedExpand
The Relevance of Complementary and Integrative Medicine in the COVID-19 Pandemic: A Qualitative Review of the Literature
CIM offers a variety of preventive and therapeutic options for strengthening physical and mental resilience, which could also be useful in the current COVID-19 pandemic. Expand
Chemistry and Pharmacology of Alkylamides from Natural Origin
This research presents a novel, scalable, scalable and scalable approaches that allow for real-time measurement of the response of the immune system to earthquake-triggered landsliding. Expand